Thrombolytic Therapy in Acute Ischemic Stroke Study, Part A "TTAISS"

Completed

Phase 2 Results

Summary of Purpose

To test the efficacy and relative safety of rtPA versus placebo.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 October 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Genentech, Inc.

Trial Design

Placebo-controlled, double-blind, randomized study of 142 patients at 42 centers.

Contacts

  • Wayne M. Clark, MD, Oregon Stroke Center, UHS 44, Oregon Health Sciences University, 3181 Sam Jackson Park Rd, Portland, OR 97201.

    clarkw@ohsu.edu